Biliary Tract Cancer Drugs
May 08, 2026
Biliary Tract Cancer: Emerging Players in the Market Transforming the Treatment Landscape
Summary BTC (including cholangiocarcinoma and gallbladder cancer) is a challenging malignancy with rising global incidence, especially in Asia and Latin America, driven by risk factors like chronic inflammation and liver flukes; ~65,000 incident cases in 7MM in 2025, projected to grow by 2036, with highest case...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
